Medical Condition News

RSS

Almirall and Absci partner to develop AI-designed therapeutics for dermatological diseases

Almirall S.A., a global biopharmaceutical company focused on medical dermatology, and Absci Corporation, a generative AI drug creation company, today announced a drug discovery partnership aimed to develop and commercialize AI-designed therapeutics to fight chronic and debilitating dermatological diseases. The partnership combines Absci’s Integrated Drug Creation™ platform with Almirall’s dermatological expertise with the goal of delivering life-changing medicines to patients, marking another step forward in AI drug creation.

20 Nov 2023

Academics' mental health articles gain cross-party praise

A bumper collection of articles from academics at The University of Manchester examining the intricacies of poor mental health and offering policy suggestions to ease the plight of sufferers has received cross-party praise from politicians in both Houses of Parliament.

20 Nov 2023

Head injuries lead to 1 hospitalization every 4 minutes in Australia

Head injuries resulted in 142,000 admitted hospital cases in 2020-21 - the equivalent of 1 hospitalization every 4 minutes, according to a report released by the Australian Institute of Health and Welfare (AIHW).

20 Nov 2023

Analysis finds 3.7 million working-age people with work-limiting health conditions

New analysis by the Health Foundation reveals that 3.7 million people (12% of the working age population) are currently in work and reporting a ‘work-limiting’ health condition that restricts the type or amount of work they can do. This has risen by 1.4 million over the past decade and almost matches the number of people with work-limiting conditions who are not in work.

20 Nov 2023

High cholesterol in midlife linked to later-life dementia

An increasing number of studies have found a significant link between higher cholesterol levels in midlife and Alzheimer's disease and dementia in later life. Swap fatty foods for healthier options this Christmas and get tested now, says a leading testing expert.

20 Nov 2023

Innovative arts-literacy program shows promise in reducing youth depression and anxiety

A RCT to assess the efficacy of the Pre-Texts arts-literacy intervention in decreasing anxiety and depression among high school pupils.

20 Nov 2023

Breakthrough in tuberculosis treatment: TB-PRACTECAL trial reveals efficacy of new oral regimen

The TB-PRACTECAL clinical trial outcomes, which evaluated the efficacy and safety of oral bedaquiline.

20 Nov 2023

Study reveals surprising trends in non-diabetic adults' use of artificial sweeteners in Brazil

The study investigates the widespread use of non-nutritive sweeteners (NNS) among non-diabetic Brazilian adults, revealing that higher education, income, and BMI increase the likelihood of regular NNS consumption, challenging the perception of NNS as a healthy alternative.

19 Nov 2023

UK's national health service diabetes program proves effective in managing prediabetes, major study finds

Researchers examined the original framework of the NHS Diabetes Prevention Programme (DPP) implemented in the UK.

19 Nov 2023

Researchers develop machine learning-based tool for assessment of shoulder function

A study published in Scientific Reports introduces a simple string-pulling task as a reliable method for assessing shoulder mobility in both animals and humans. This innovative approach, combined with machine learning, has the potential to revolutionize the diagnosis and monitoring of shoulder injuries, offering an affordable and accessible solution.

19 Nov 2023

Machine learning uncovers potent immunomodulators for vaccines and immunotherapy

Small molecules called immunomodulators can help create more effective vaccines and stronger immunotherapies to treat cancer.

17 Nov 2023

Stem-cell-derived brain cells hold promise for Alzheimer's, Parkinson's research

Researchers at the University of Wisconsin–Madison have identified a protein key to the development of a type of brain cell believed to play a role in disorders like Alzheimer's and Parkinson's diseases and used the discovery to grow the neurons from stem cells for the first time.

17 Nov 2023

Norwegian study looks at which medicines best prevent migraine

Migraine is more than just a headache. Often the pain is accompanied by nausea, vomiting, light sensitivity, and sound sensitivity.

17 Nov 2023

Benzodiazepine prescribing practices for homeless veterans with mental illness

Despite elevated risk for substance use disorder and overdose death in the homeless population, benzodiazepine prescribing for this population has not been examined.

17 Nov 2023

Study links nanoplastics to Parkinson's disease and dementia

Nanoplastics interact with a particular protein that is naturally found in the brain, creating changes linked to Parkinson's disease and some types of dementia.

17 Nov 2023

New understanding of lung cancer cells' 'memories' suggests novel treatment approach

A new understanding of lung cancer cells' "memories" suggests a new strategy for improving treatment, Memorial Sloan Kettering Cancer Center (MSK) researchers have found.

17 Nov 2023

Researchers identify a promising new strategy for glaucoma cell replacement therapy

Glaucoma is one of the leading causes of blindness worldwide, and vision loss, due to the loss of retinal ganglion cells (RGCs), cannot currently be reversed with any treatment.

17 Nov 2023

Unraveling the immune system's response to nanoparticle drug delivery

To reduce the side effects associated with chemotherapy treatments, researchers have investigated the use of delivery systems that can take more drugs directly to the tumor. Ninh (Irene) La-Beck, Pharm.D., from the Department of Immunotherapeutics and Biotechnology at the Texas Tech University Health Sciences Center (TTUHSC) Jerry H. Hodge School of Pharmacy is one of those researchers.

17 Nov 2023

Assessing DDX53 as a potential early esophageal cancer antigen

A new research paper was published in Oncoscience (Volume 10) on November 10, 2023, entitled, "An immunoinformatics assessment of the cancer testis antigen, DDX53, as a potential early esophageal cancer antigen."

17 Nov 2023

Injectable grain-of-rice-sized glucose monitor could revolutionize diabetes management

The first glucose self-monitoring system created in 1970 weighed three pounds, was initially designed only for physicians' offices and needed a large drop of blood for a reading.

17 Nov 2023

Medical Condition News

Almirall and Absci partner to develop AI-designed therapeutics for dermatological diseases

Academics' mental health articles gain cross-party praise

Head injuries lead to 1 hospitalization every 4 minutes in Australia

Analysis finds 3.7 million working-age people with work-limiting health conditions

High cholesterol in midlife linked to later-life dementia

Innovative arts-literacy program shows promise in reducing youth depression and anxiety

Breakthrough in tuberculosis treatment: TB-PRACTECAL trial reveals efficacy of new oral regimen

Study reveals surprising trends in non-diabetic adults' use of artificial sweeteners in Brazil

UK's national health service diabetes program proves effective in managing prediabetes, major study finds

Researchers develop machine learning-based tool for assessment of shoulder function

Machine learning uncovers potent immunomodulators for vaccines and immunotherapy

Stem-cell-derived brain cells hold promise for Alzheimer's, Parkinson's research

Norwegian study looks at which medicines best prevent migraine

Benzodiazepine prescribing practices for homeless veterans with mental illness

Study links nanoplastics to Parkinson's disease and dementia

New understanding of lung cancer cells' 'memories' suggests novel treatment approach

Researchers identify a promising new strategy for glaucoma cell replacement therapy

Unraveling the immune system's response to nanoparticle drug delivery

Assessing DDX53 as a potential early esophageal cancer antigen

Injectable grain-of-rice-sized glucose monitor could revolutionize diabetes management

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News